INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

CORCencora, Inc.

CIK 0001140859

EDGAR filingsOpen in network
Disclosed transactions36
Buys / sells4 / 6
Max Insider Score39
Connections15with evidence

COR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Open-market sale
SELL$3.66M
11.3K sh
Aug 24, 2026Aug 25, 2026
traded Aug 24, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Nov 4, 2026
  • ← Connected organizationevidence
    CENCORA, INC. PACFEC Form 1 connected organization: CENCORA, INC. (exact legal-name match) · Nov 4, 2026
  • ← Lobbied forevidence
    THE DUBERSTEIN GROUP INC.LDA Q1 2026 first quarter · Trade, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    TCH GROUP, LLCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
11
BS
Battaglia SilvanaExecutive Vice President
CORCencora, Inc.
Grant or award
A
$14K
58 sh
Jun 30, 2026
Jul 7, 2026
traded Jun 30, 2026
+7d
SEC FORM 4

Evidence

11
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Grant or award
A$12K
50 sh
Jun 30, 2026Jul 7, 2026
traded Jun 30, 2026
+7dSEC FORM 4

Evidence

36
TM
Tyler Lauren MDirector
CORCencora, Inc.
Open-market purchase
BUY$149K
550 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC FORM 4

Evidence

31
Jared MoskowitzDSelf
CORCencora, Inc.
Sale
SELL$1,001 – $15KMay 6, 2026Jun 19, 2026
traded May 6, 2026
+44dHOUSE PTR

Evidence

31
Jared MoskowitzDDependent child
CORCencora, Inc.
Sale
SELL$1,001 – $15KMay 6, 2026Jun 19, 2026
traded May 6, 2026
+44dHOUSE PTR

Evidence

28
Jared MoskowitzDSelf
CORCencora, Inc.
Purchase
BUY$1,001 – $15KMar 23, 2026Apr 30, 2026
traded Mar 23, 2026
+38dHOUSE PTR

Evidence

20
Jared MoskowitzDSelf
CORCencora, Inc.
Purchase
BUY$1,001 – $15KMar 31, 2026Apr 30, 2026
traded Mar 31, 2026
+30dHOUSE PTR

Evidence

28
Jared MoskowitzDDependent child
CORCencora, Inc.
Purchase
BUY$1,001 – $15KMar 23, 2026Apr 30, 2026
traded Mar 23, 2026
+38dHOUSE PTR

Evidence

22
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Tax withholding
F$2.05M
5,842 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

5
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
12.6K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

17
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
12.6K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

16
BW
Baumann WernerDirector
CORCencora, Inc.
Grant or award
A$200K
557 sh
Mar 5, 2026Mar 9, 2026
traded Mar 5, 2026
+4dSEC FORM 4

Evidence

18
MP
Mauch Robert P.Director, President & CEO
CORCencora, Inc.
Open-market sale · 10b5-1 plan
SELL$1.81M
5,096 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

0
MP
Mauch Robert P.Director, President & CEO
CORCencora, Inc.
Option exercise · 10b5-1 plan
M—
3,763 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

9
MP
Mauch Robert P.Director, President & CEO
CORCencora, Inc.
Option exercise · 10b5-1 plan
M$324K
3,763 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC FORM 4

Evidence

11
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Grant or award
A$9,625
34 sh
Dec 31, 2025Jan 7, 2026
traded Dec 31, 2025
+7dSEC FORM 4

Evidence

11
BS
Battaglia SilvanaExecutive Vice President
CORCencora, Inc.
Grant or award
A$7,850
27 sh
Dec 31, 2025Jan 7, 2026
traded Dec 31, 2025
+7dSEC FORM 4

Evidence

39
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Open-market sale
SELL$1.15M
3,351 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

36
BS
Battaglia SilvanaExecutive Vice President
CORCencora, Inc.
Open-market sale
SELL$579K
1,677 sh
Dec 19, 2025Dec 22, 2025
traded Dec 19, 2025
+3dSEC FORM 4

Evidence

16
NM
Nally Dennis MDirector
CORCencora, Inc.
Gift
G—
1,173 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC FORM 4

Evidence

13
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
1,590 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC FORM 4

Evidence

21
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
1,590 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC FORM 4

Evidence

15
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Tax withholding
F$266K
736 sh
Nov 20, 2025Nov 24, 2025
traded Nov 20, 2025
+4dSEC FORM 4

Evidence

9
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Grant or award
A—
3,523 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence

9
BS
Battaglia SilvanaExecutive Vice President
CORCencora, Inc.
Grant or award
A—
2,202 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC FORM 4

Evidence

21
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Grant or award
A—
20.6K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC FORM 4

Evidence

26
BS
Battaglia SilvanaExecutive Vice President
CORCencora, Inc.
Tax withholding
F$1.75M
5,612 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC FORM 4

Evidence

30
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Tax withholding
F$2.98M
9,532 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC FORM 4

Evidence

21
BS
Battaglia SilvanaExecutive Vice President
CORCencora, Inc.
Grant or award
A—
12.9K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC FORM 4

Evidence

19
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
1,830 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

25
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Tax withholding
F$288K
798 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

19
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
2,023 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
1,830 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

15
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
2,023 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

18
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Tax withholding
F$206K
572 sh
Nov 7, 2025Nov 12, 2025
traded Nov 7, 2025
+5dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    INLET STRATEGIESLDA Q1 2026 first quarter · Health issues, Taxation, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    MONUMENT ADVOCACYLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    HARBINGER STRATEGIES, LLCLDA Q2 2026 second quarter · Health issues, Taxation, Defense · Aug 26, 2026
  • ← Lobbied forevidence
    BROWNSTEIN HYATT FARBER SCHRECK, LLPLDA Q2 2026 second quarter · Pharmacy, Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Tyler Lauren MDirector · Jun 24, 2026
  • ← Disclosed trade inevidence
    Jared MoskowitzSale disclosed 2026-06-19 · Jun 19, 2026
  • ← Insider ofevidence
    Baumann WernerDirector · Mar 9, 2026
  • ← Insider ofevidence
    Mauch Robert P.Director, President & CEO · Jan 22, 2026
  • ← Insider ofevidence
    Nally Dennis MDirector · Dec 19, 2025
  • ← Insider ofevidence
    Battaglia SilvanaExecutive Vice President · Nov 14, 2025
  • ← Insider ofevidence
    Campbell Elizabeth SExecutive Vice President · Nov 12, 2025

    • Lobbying

    $1.66M reported · de-duplicated
    2026 Q2 $510K in-house2026 Q1 $1.15M in-house
    • BROWNSTEIN HYATT FARBER SCHRECK, LLP$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Pharmacy
    • In-house report$1.15M2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Pharmacy, Health issues, Taxation, Trade
    • INLET STRATEGIES$30K2026 Q1 · posted Aug 26, 2026 · Health issues, Taxation, Medicare/Medicaid
    • HARBINGER STRATEGIES, LLC$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Taxation, Defense
    • MONUMENT ADVOCACY—2026 Q1 · posted Aug 26, 2026 · Health issues
    • In-house report$510K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Pharmacy, Health issues, Taxation, Trade
    • THE DUBERSTEIN GROUP INC.$75K2026 Q1 · posted Aug 26, 2026 · Trade, Health issues
    • TCH GROUP, LLC$30K2026 Q1 · posted Aug 26, 2026 · Health issues
    • THE DUBERSTEIN GROUP INC.$75K2026 Q2 · posted Aug 26, 2026 · Trade, Health issues
    • BROWNSTEIN HYATT FARBER SCHRECK, LLP$60K2026 Q2 · posted Aug 26, 2026 · Pharmacy, Health issues
    • TCH GROUP, LLC$30K2026 Q2 · posted Aug 26, 2026 · Health issues
    • INLET STRATEGIES$30K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues, Taxation

    Connected PAC contributions

    FEC · direct to members
    • Mary Gay ScanlonD$10KCENCORA, INC. PAC
    • Mike JohnsonR$10KCENCORA, INC. PAC
    • Frank Pallone, Jr.D$9,500CENCORA, INC. PAC
    • Gregory F. MurphyR$9,000CENCORA, INC. PAC
    • Jon HustedR$8,500CENCORA, INC. PAC
    • Brett Guthrie
    R
    $8,500
    CENCORA, INC. PAC
  • Angela D. AlsobrooksD$7,500CENCORA, INC. PAC
  • Lori TrahanD$7,500CENCORA, INC. PAC
  • Nanette Diaz BarragánD$7,500CENCORA, INC. PAC
  • Diana HarshbargerR$7,500CENCORA, INC. PAC
  • Carol D. MillerR$7,500CENCORA, INC. PAC
  • Blake D. MooreR$7,000CENCORA, INC. PAC